Premium Nahrungsergänzungsmittel | artgerecht

IDDM - Insulin-Dependent Diabetes Mellitus Explained

IDDM (insulin-dependent diabetes mellitus) is the former medical term for Type 1 diabetes, an autoimmune disease in which the pancreas produces little or no insulin.

Regular tips about health Regular tips about health

Things worth knowing about "IDDM"

IDDM (insulin-dependent diabetes mellitus) is the former medical term for Type 1 diabetes, an autoimmune disease in which the pancreas produces little or no insulin.

What is IDDM?

IDDM stands for insulin-dependent diabetes mellitus and is the older medical term for what is now widely known as Type 1 diabetes. The term is still found frequently in older clinical literature and medical records. IDDM is a chronic metabolic disorder in which the insulin-producing beta cells of the pancreas are destroyed by the body's own immune system. Because little or no insulin is produced, people with IDDM depend on lifelong external insulin supply to survive.

Causes

IDDM is classified as an autoimmune disease. The immune system mistakenly attacks and destroys the beta cells located in the islets of Langerhans within the pancreas. While the exact triggers are not fully understood, the following factors are known to play a role:

Genetic predisposition: Certain HLA (Human Leukocyte Antigen) gene variants significantly increase the risk of developing IDDM.
Environmental triggers: Viral infections such as Coxsackievirus or rubella may initiate or accelerate the autoimmune response.
Epigenetic and microbiome factors: Early childhood diet and gut microbiome composition are currently under investigation as potential contributing factors.

Symptoms

Symptoms of IDDM result from insulin deficiency and the resulting elevated blood glucose levels (hyperglycemia). Common signs and symptoms include:

Excessive thirst (polydipsia)
Frequent urination (polyuria)
Unexplained weight loss
Extreme fatigue and weakness
Blurred vision
In advanced or undiagnosed cases: diabetic ketoacidosis (DKA), a life-threatening complication caused by the accumulation of ketone bodies in the blood

Diagnosis

The diagnosis of IDDM is established through blood tests and clinical evaluation:

Fasting blood glucose: A value above 126 mg/dL (7.0 mmol/L) on two separate occasions confirms diabetes.
HbA1c level: A long-term blood glucose marker above 6.5% (48 mmol/mol) indicates diabetes.
Autoantibody testing: Detection of islet cell antibodies (ICA), anti-GAD antibodies, or IA-2 antibodies confirms the autoimmune origin of the disease.
C-peptide measurement: Low or undetectable C-peptide levels indicate minimal or absent insulin production.

Treatment

Because the beta cells are permanently destroyed, lifelong insulin therapy is essential. Treatment approaches include:

Insulin Therapy

People with IDDM require regular insulin injections or continuous insulin delivery through an insulin pump. A combination of short-acting and long-acting insulin analogs is used to mimic the natural insulin rhythm of the body, known as basal-bolus therapy.

Blood Glucose Monitoring

Regular blood glucose checks -- increasingly supported by continuous glucose monitoring (CGM) devices -- are essential to prevent both low blood sugar (hypoglycemia) and high blood sugar (hyperglycemia).

Diet and Lifestyle

A carbohydrate-conscious diet and regular physical activity help stabilize blood glucose levels and reduce the risk of long-term complications such as kidney damage, retinal damage, and nerve damage.

Diabetes Education and Self-Management

Structured diabetes education programs are a key component of care. Patients learn how to adjust their insulin doses independently and respond appropriately to changes in daily routines, illness, or physical activity.

Long-Term Complications

Poorly controlled IDDM can lead to serious long-term complications affecting multiple organ systems:

Diabetic retinopathy (damage to the retina of the eye)
Diabetic nephropathy (kidney damage)
Diabetic neuropathy (nerve damage, often affecting the feet and hands)
Cardiovascular disease (increased risk of heart attack and stroke)

References

American Diabetes Association - Standards of Medical Care in Diabetes (2024). Diabetes Care, 47(Suppl 1).
Atkinson MA, Eisenbarth GS, Michels AW - Type 1 diabetes. The Lancet, 383(9911):69-82 (2014).
World Health Organization (WHO) - Classification of Diabetes Mellitus. Geneva: WHO (2019).

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category